These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Gene therapy of cystic fibrosis]. Rochat T Schweiz Med Wochenschr; 1999 Nov; 129(46):1779-83. PubMed ID: 10603652 [TBL] [Abstract][Full Text] [Related]
23. [Cystic fibrosis lung disease and its management]. Hidaka N; Hidaka Y Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420 [TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis: from a single gene to complex pathophysiology. Kargul J; Irminger-Finger I Int J Biochem Cell Biol; 2014 Jul; 52():1. PubMed ID: 24792669 [No Abstract] [Full Text] [Related]
25. Cystic fibrosis, a multi-systemic mucosal disease: 25 years after the discovery of CFTR. Edelman A; Sallenave JM Int J Biochem Cell Biol; 2014 Jul; 52():2-4. PubMed ID: 24735713 [No Abstract] [Full Text] [Related]
31. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism. Gelman MS; Kopito RR Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537 [No Abstract] [Full Text] [Related]
32. [New therapeutic approaches to Cystic fibrosis]. Willemot JM; Sermet Gaudelus I; Lenoir G Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958 [TBL] [Abstract][Full Text] [Related]
33. Twenty years after cystic fibrosis gene identification: Where are we and what are we up to? Edelman A; Fritsch J; Ollero M Pathol Biol (Paris); 2011 Jun; 59(3):131-3. PubMed ID: 19896304 [No Abstract] [Full Text] [Related]
34. Understanding cystic fibrosis, improving life expectancy. Bentley P Nurs Times; 1999 Oct 27-Nov 2; 95(43):50-1. PubMed ID: 10847084 [No Abstract] [Full Text] [Related]
35. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis. Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421 [No Abstract] [Full Text] [Related]
36. [Challenges of personalized medicine for cystic fibrosis]. Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452 [TBL] [Abstract][Full Text] [Related]
37. Making precision medicine personal for cystic fibrosis. Manfredi C; Tindall JM; Hong JS; Sorscher EJ Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522 [No Abstract] [Full Text] [Related]
38. Genetic testing to provide targeted treatment for cystic fibrosis patients. Edelman A; Sermet-Gaudelus I; Rousset JP Pharmacogenomics; 2007 Sep; 8(9):1101-4. PubMed ID: 17924824 [No Abstract] [Full Text] [Related]
39. [Pathophysiology and therapy of mucoviscidosis]. Bachert C HNO; 1996 Apr; 44(4):167-8. PubMed ID: 8655345 [No Abstract] [Full Text] [Related]
40. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. Cohn JA; Mitchell RM; Jowell PS Gastroenterol Clin North Am; 2004 Dec; 33(4):817-37, vii. PubMed ID: 15528020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]